StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$33.27+0.77 (+2.37%)

Close on Nov 18, 2026Market cap $155.75MP/E –Yield –

Korsana Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Korsana Biosciences's market cap was $135.52M on Nov 11, 2026, against $40.87M a year earlier. Over the last 5 years it ranged from $11.76M to $521.44M, with a median of $61.48M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$135.52M+312.6%
2025Dec 31, 2025$32.85M-42.4%
2024Dec 31, 2024$57.05M-0.5%
2023Dec 29, 2023$57.34M-71.3%
2022Dec 30, 2022$199.78M-61.7%
2021Dec 31, 2021$521.44M-28.3%
2020Dec 31, 2020$727.44M+39.1%
2019Dec 31, 2019$522.99M–

More Korsana Biosciences figures

See a number that looks wrong?